Trial Profile
PILOT STUDY OF GENE THERAPY FOR LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA WITH INTRATUMOURAL INJECTION OF JetPEI/DNA COMPLEXES WITH ANTITUMOURAL EFFECT AND CHEMOSENSITIZING ACTIVITY FOR GEMCITABINE.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Mar 2016
Price :
$35
*
At a glance
- Drugs CYL 02 (Primary) ; Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- Acronyms TherGAP
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jan 2011 New trial record